Datamonitor: Metabolic Syndrome Epidemic

August 16, 2004

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

LONDONMetabolic syndrome, a cluster of metabolic disorders including obesity, pre-diabetes, abnormal lipid levels and high blood pressure, is approaching epidemic proportions worldwide, according to a new report from market analyst Datamonitor. It estimated approximately 115 million people in the United States, Japan, France, Germany, Italy, Spain and the United Kingdom suffer from metabolic syndrome, which is poorly diagnosed and difficult to treat comprehensively. In the report, "Metabolic SyndromeA Ticking Time Bomb," Datamonitor (www.datamonitor.com) suggests single pill combination therapies from companies including AstraZeneca and Bristol-Myers Squibb may be well positioned to treat the condition.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like